HEADER HYDROLASE 27-JUN-24 9FVO TITLE THE HIV PROTEASE INHIBITOR AMPRENAVIR BINDING TO THE ACTIVE SITE OF TITLE 2 CRYPHONECTRIA PARASITICA ENDOTHIAPEPSIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDOTHIAPEPSIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ASPARTATE PROTEASE; COMPND 5 EC: 3.4.23.22; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CRYPHONECTRIA PARASITICA; SOURCE 3 ORGANISM_COMMON: CHESTNUT BLIGHT FUNGUS; SOURCE 4 ORGANISM_TAXID: 5116; SOURCE 5 GENE: EAPA, EPN-1; SOURCE 6 EXPRESSION_SYSTEM: CRYPHONECTRIA PARASITICA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 5116 KEYWDS ASPARTIC PROTEASE, DRUG DEVELOPMENT, INHIBITOR, X-RAY KEYWDS 2 CRYSTALLOGRAPHIC SCREENING, CHESTNUT BLIGHT FUNGUS, PROTEASE MODEL., KEYWDS 3 HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR S.FALKE,J.M.SENST,S.GUENTHER,A.MEENTS REVDAT 1 10-JUL-24 9FVO 0 JRNL AUTH S.FALKE,J.M.SENST,S.GUENTHER,A.MEENTS JRNL TITL THE HIV PROTEASE INHIBITOR AMPRENAVIR BINDING TO THE ACTIVE JRNL TITL 2 SITE OF CRYPHONECTRIA PARASITICA ENDOTHIAPEPSIN JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20-4459-9999 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.03 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 30097 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.143 REMARK 3 R VALUE (WORKING SET) : 0.141 REMARK 3 FREE R VALUE : 0.172 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.650 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.0300 - 4.3400 1.00 2091 149 0.1353 0.1547 REMARK 3 2 4.3400 - 3.4400 0.95 1947 139 0.1319 0.1675 REMARK 3 3 3.4400 - 3.0100 1.00 2026 143 0.1571 0.1716 REMARK 3 4 3.0100 - 2.7300 0.99 2033 145 0.1538 0.1744 REMARK 3 5 2.7300 - 2.5400 1.00 2011 144 0.1443 0.1856 REMARK 3 6 2.5400 - 2.3900 0.99 2019 143 0.1374 0.1559 REMARK 3 7 2.3900 - 2.2700 0.99 2034 145 0.1332 0.1593 REMARK 3 8 2.2700 - 2.1700 1.00 2026 144 0.1381 0.1700 REMARK 3 9 2.1700 - 2.0900 0.95 1907 136 0.1322 0.1771 REMARK 3 10 2.0900 - 2.0100 0.97 1964 139 0.1328 0.1804 REMARK 3 11 2.0100 - 1.9500 0.99 2019 145 0.1325 0.2035 REMARK 3 12 1.9500 - 1.8900 0.99 1999 142 0.1396 0.1702 REMARK 3 13 1.8900 - 1.8500 1.00 2006 142 0.1515 0.1766 REMARK 3 14 1.8400 - 1.8000 1.00 2015 144 0.1589 0.2186 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.152 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 15.752 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 14.62 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.74 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.012 2604 REMARK 3 ANGLE : 1.006 3545 REMARK 3 CHIRALITY : 0.070 411 REMARK 3 PLANARITY : 0.007 449 REMARK 3 DIHEDRAL : 9.818 436 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9FVO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-JUN-24. REMARK 100 THE DEPOSITION ID IS D_1292139771. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-NOV-23 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PETRA III, DESY REMARK 200 BEAMLINE : P11 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.826501 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30224 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 43.030 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 13.69 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 23.7500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.84 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX 1.20-4459-9999 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.14 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.47 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 24% (W/V) PEG 4000, 0.1 M AMMONIUM REMARK 280 ACETATE AND 0.1 M SODIUM ACETATE PH 4.6 WERE MIXED WITH AN EQUAL REMARK 280 VOLUME OF 6 MG/ML ENDOTHIAPEPSIN SOLUTION. MICROSEEDING WAS REMARK 280 APPLIED. AFTER 2 DAYS CRYSTALS WERE SOAKED WITH THE LIGAND IN REMARK 280 RESERVOIR SOLUTION IN THE PRESENCE OF 5% (V/V) DMSO, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 36.41600 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2910 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13540 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 28.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 766 O HOH A 781 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 39 25.06 -140.06 REMARK 500 ALA A 129 -166.91 -77.44 REMARK 500 ALA A 320 172.97 -55.27 REMARK 500 REMARK 500 REMARK: NULL DBREF 9FVO A 1 330 UNP P11838 CARP_CRYPA 90 419 SEQRES 1 A 330 SER THR GLY SER ALA THR THR THR PRO ILE ASP SER LEU SEQRES 2 A 330 ASP ASP ALA TYR ILE THR PRO VAL GLN ILE GLY THR PRO SEQRES 3 A 330 ALA GLN THR LEU ASN LEU ASP PHE ASP THR GLY SER SER SEQRES 4 A 330 ASP LEU TRP VAL PHE SER SER GLU THR THR ALA SER GLU SEQRES 5 A 330 VAL ASP GLY GLN THR ILE TYR THR PRO SER LYS SER THR SEQRES 6 A 330 THR ALA LYS LEU LEU SER GLY ALA THR TRP SER ILE SER SEQRES 7 A 330 TYR GLY ASP GLY SER SER SER SER GLY ASP VAL TYR THR SEQRES 8 A 330 ASP THR VAL SER VAL GLY GLY LEU THR VAL THR GLY GLN SEQRES 9 A 330 ALA VAL GLU SER ALA LYS LYS VAL SER SER SER PHE THR SEQRES 10 A 330 GLU ASP SER THR ILE ASP GLY LEU LEU GLY LEU ALA PHE SEQRES 11 A 330 SER THR LEU ASN THR VAL SER PRO THR GLN GLN LYS THR SEQRES 12 A 330 PHE PHE ASP ASN ALA LYS ALA SER LEU ASP SER PRO VAL SEQRES 13 A 330 PHE THR ALA ASP LEU GLY TYR HIS ALA PRO GLY THR TYR SEQRES 14 A 330 ASN PHE GLY PHE ILE ASP THR THR ALA TYR THR GLY SER SEQRES 15 A 330 ILE THR TYR THR ALA VAL SER THR LYS GLN GLY PHE TRP SEQRES 16 A 330 GLU TRP THR SER THR GLY TYR ALA VAL GLY SER GLY THR SEQRES 17 A 330 PHE LYS SER THR SER ILE ASP GLY ILE ALA ASP THR GLY SEQRES 18 A 330 THR THR LEU LEU TYR LEU PRO ALA THR VAL VAL SER ALA SEQRES 19 A 330 TYR TRP ALA GLN VAL SER GLY ALA LYS SER SER SER SER SEQRES 20 A 330 VAL GLY GLY TYR VAL PHE PRO CYS SER ALA THR LEU PRO SEQRES 21 A 330 SER PHE THR PHE GLY VAL GLY SER ALA ARG ILE VAL ILE SEQRES 22 A 330 PRO GLY ASP TYR ILE ASP PHE GLY PRO ILE SER THR GLY SEQRES 23 A 330 SER SER SER CYS PHE GLY GLY ILE GLN SER SER ALA GLY SEQRES 24 A 330 ILE GLY ILE ASN ILE PHE GLY ASP VAL ALA LEU LYS ALA SEQRES 25 A 330 ALA PHE VAL VAL PHE ASN GLY ALA THR THR PRO THR LEU SEQRES 26 A 330 GLY PHE ALA SER LYS HET 478 A 401 70 HET PG4 A 402 31 HET PG4 A 403 31 HET PGE A 404 24 HET PGE A 405 24 HET EDO A 406 10 HET ACY A 407 7 HET PG4 A 408 31 HET ACY A 409 7 HET EDO A 410 10 HET EDO A 411 10 HETNAM 478 {3-[(4-AMINO-BENZENESULFONYL)-ISOBUTYL-AMINO]-1-BENZYL- HETNAM 2 478 2-HYDROXY-PROPYL}-CARBAMIC ACID TETRAHYDRO-FURAN-3-YL HETNAM 3 478 ESTER HETNAM PG4 TETRAETHYLENE GLYCOL HETNAM PGE TRIETHYLENE GLYCOL HETNAM EDO 1,2-ETHANEDIOL HETNAM ACY ACETIC ACID HETSYN 478 AMPRENAVIR HETSYN EDO ETHYLENE GLYCOL FORMUL 2 478 C25 H35 N3 O6 S FORMUL 3 PG4 3(C8 H18 O5) FORMUL 5 PGE 2(C6 H14 O4) FORMUL 7 EDO 3(C2 H6 O2) FORMUL 8 ACY 2(C2 H4 O2) FORMUL 13 HOH *295(H2 O) HELIX 1 AA1 THR A 49 VAL A 53 5 5 HELIX 2 AA2 THR A 60 SER A 64 5 5 HELIX 3 AA3 SER A 113 ASP A 119 1 7 HELIX 4 AA4 PHE A 130 ASN A 134 5 5 HELIX 5 AA5 THR A 143 LYS A 149 1 7 HELIX 6 AA6 ALA A 150 LEU A 152 5 3 HELIX 7 AA7 PRO A 228 ALA A 237 1 10 HELIX 8 AA8 PRO A 274 TYR A 277 5 4 HELIX 9 AA9 GLY A 306 LYS A 311 1 6 SHEET 1 AA1 9 LYS A 68 SER A 78 0 SHEET 2 AA1 9 SER A 84 VAL A 96 -1 O VAL A 89 N LEU A 70 SHEET 3 AA1 9 TYR A 17 ILE A 23 -1 N GLN A 22 O SER A 95 SHEET 4 AA1 9 GLY A 3 PRO A 9 -1 N THR A 8 O ILE A 18 SHEET 5 AA1 9 GLY A 167 PHE A 171 -1 O PHE A 171 N GLY A 3 SHEET 6 AA1 9 VAL A 156 ASP A 160 -1 N THR A 158 O ASN A 170 SHEET 7 AA1 9 PHE A 314 ASN A 318 -1 O PHE A 317 N PHE A 157 SHEET 8 AA1 9 THR A 324 ALA A 328 -1 O GLY A 326 N VAL A 316 SHEET 9 AA1 9 THR A 184 ALA A 187 -1 N THR A 186 O LEU A 325 SHEET 1 AA213 LYS A 68 SER A 78 0 SHEET 2 AA213 SER A 84 VAL A 96 -1 O VAL A 89 N LEU A 70 SHEET 3 AA213 LEU A 99 VAL A 112 -1 O VAL A 106 N TYR A 90 SHEET 4 AA213 LEU A 41 VAL A 43 1 N LEU A 41 O GLU A 107 SHEET 5 AA213 GLY A 124 GLY A 127 -1 O LEU A 125 N TRP A 42 SHEET 6 AA213 GLN A 28 ASP A 35 1 N ASP A 35 O LEU A 126 SHEET 7 AA213 TYR A 17 ILE A 23 -1 N ILE A 23 O GLN A 28 SHEET 8 AA213 GLY A 3 PRO A 9 -1 N THR A 8 O ILE A 18 SHEET 9 AA213 GLY A 167 PHE A 171 -1 O PHE A 171 N GLY A 3 SHEET 10 AA213 VAL A 156 ASP A 160 -1 N THR A 158 O ASN A 170 SHEET 11 AA213 PHE A 314 ASN A 318 -1 O PHE A 317 N PHE A 157 SHEET 12 AA213 THR A 324 ALA A 328 -1 O GLY A 326 N VAL A 316 SHEET 13 AA213 THR A 184 ALA A 187 -1 N THR A 186 O LEU A 325 SHEET 1 AA3 7 ALA A 269 ILE A 273 0 SHEET 2 AA3 7 PHE A 262 VAL A 266 -1 N PHE A 262 O ILE A 273 SHEET 3 AA3 7 GLU A 196 VAL A 204 -1 N ALA A 203 O THR A 263 SHEET 4 AA3 7 LYS A 210 ALA A 218 -1 O LYS A 210 N TYR A 202 SHEET 5 AA3 7 ASN A 303 PHE A 305 1 O PHE A 305 N ILE A 217 SHEET 6 AA3 7 LEU A 225 LEU A 227 -1 N TYR A 226 O ILE A 304 SHEET 7 AA3 7 ILE A 294 SER A 296 1 O GLN A 295 N LEU A 225 SHEET 1 AA4 4 LYS A 243 SER A 245 0 SHEET 2 AA4 4 GLY A 250 PRO A 254 -1 O GLY A 250 N SER A 245 SHEET 3 AA4 4 SER A 289 GLY A 292 -1 O CYS A 290 N PHE A 253 SHEET 4 AA4 4 ASP A 279 PRO A 282 -1 N GLY A 281 O PHE A 291 SSBOND 1 CYS A 255 CYS A 290 1555 1555 2.06 CISPEP 1 THR A 25 PRO A 26 0 -8.59 CISPEP 2 SER A 137 PRO A 138 0 1.63 CRYST1 45.638 72.832 53.230 90.00 109.46 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021912 0.000000 0.007742 0.00000 SCALE2 0.000000 0.013730 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019925 0.00000